Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Biospecimen collection, processing, and analysis: new challenges for oncology nurses.

Neumann RM, Garvey C, Kaufman S.

Semin Oncol Nurs. 2014 May;30(2):117-23. doi: 10.1016/j.soncn.2014.03.005. Review.

PMID:
24794085
2.
3.

Role of chain entropy in an analytic model of protein binding in single-DNA stretching experiments.

Lam PM, Neumann RM.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Sep;84(3 Pt 1):032901. Epub 2011 Sep 7.

PMID:
22060437
4.

Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.

Zheng L, Wang F, Qian C, Neumann RM, Cheville JC, Tindall DJ, Liu W.

Hum Mutat. 2006 Oct;27(10):1062-3.

PMID:
16941491
5.

PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.

Vanaja DK, Ballman KV, Morlan BW, Cheville JC, Neumann RM, Lieber MM, Tindall DJ, Young CY.

Clin Cancer Res. 2006 Feb 15;12(4):1128-36.

6.

Phyllodes tumor of the prostate: long-term followup study of 23 cases.

Bostwick DG, Hossain D, Qian J, Neumann RM, Yang P, Young RH, di Sant'agnese PA, Jones EC.

J Urol. 2004 Sep;172(3):894-9.

PMID:
15310992
7.
8.

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H, Bostwick DG.

Cancer. 2000 May 15;88(10):2326-32.

PMID:
10820355
9.

Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG.

Cancer. 2000 Apr 1;88(7):1663-70.

PMID:
10738225
10.

Paraganglioma of the urinary bladder: can biologic potential be predicted?

Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Neumann RM, Nascimento AG, Zincke H, Bostwick DG.

Cancer. 2000 Feb 15;88(4):844-52.

PMID:
10679654
11.

Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.

Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, Scherer BG, Nehra A, Zincke H, Bostwick DG.

Am J Clin Pathol. 2000 Feb;113(2):275-9.

PMID:
10664630
12.

Flat intraepithelial lesions of the urinary bladder.

Cheng L, Cheville JC, Neumann RM, Bostwick DG.

Cancer. 2000 Feb 1;88(3):625-31.

PMID:
10649257
13.

Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications.

Cheng L, Neumann RM, Bostwick DG.

Cancer. 1999 Nov 15;86(10):2102-8.

PMID:
10570438
14.

Urothelial papilloma of the bladder. Clinical and biologic implications.

Cheng L, Darson M, Cheville JC, Neumann RM, Zincke H, Nehra A, Bostwick DG.

Cancer. 1999 Nov 15;86(10):2098-101.

PMID:
10570437
15.

Predicting cancer progression in patients with stage T1 bladder carcinoma.

Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG.

J Clin Oncol. 1999 Oct;17(10):3182-7.

PMID:
10506616
16.

Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.

Cheng L, Weaver AL, Neumann RM, Scherer BG, Bostwick DG.

Cancer. 1999 Sep 15;86(6):1035-43.

PMID:
10491531
17.

Hemangioma of the urinary bladder.

Cheng L, Nascimento AG, Neumann RM, Nehra A, Cheville JC, Ramnani DM, Leibovich BC, Bostwick DG.

Cancer. 1999 Aug 1;86(3):498-504. Review.

PMID:
10430259
18.

Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy.

Cheng L, Cheville JC, Pisansky TM, Sebo TJ, Slezak J, Bergstralh EJ, Neumann RM, Singh R, Pacelli A, Zincke H, Bostwick DG.

Am J Surg Pathol. 1999 Jul;23(7):803-8.

PMID:
10403303
19.

Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion.

Cheng L, Neumann RM, Scherer BG, Weaver AL, Leibovich BC, Nehra A, Zincke H, Bostwick DG.

Cancer. 1999 Jun 15;85(12):2638-47.

PMID:
10375113
20.

Survival of patients with carcinoma in situ of the urinary bladder.

Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, Bostwick DG.

Cancer. 1999 Jun 1;85(11):2469-74.

PMID:
10357420
21.

Natural history of urothelial dysplasia of the bladder.

Cheng L, Cheville JC, Neumann RM, Bostwick DG.

Am J Surg Pathol. 1999 Apr;23(4):443-7.

PMID:
10199474
22.

Predictors of cancer progression in T1a prostate adenocarcinoma.

Cheng L, Bergstralh EJ, Scherer BG, Neumann RM, Blute ML, Zincke H, Bostwick DG.

Cancer. 1999 Mar 15;85(6):1300-4.

PMID:
10189135
23.

p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.

Cheng L, Sebo TJ, Cheville JC, Pisansky TM, Slezak J, Bergstralh EJ, Pacelli A, Neumann RM, Zincke H, Bostwick DG.

Cancer. 1999 Mar 15;85(6):1293-9.

PMID:
10189134
24.

Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy.

Cheng L, Sebo TJ, Slezak J, Pisansky TM, Bergstralh EJ, Neumann RM, Iczkowski KA, Zincke H, Bostwick DG.

Cancer. 1998 Nov 15;83(10):2164-71.

PMID:
9827721
25.

Long-term follow-up of untreated stage T1a prostate cancer.

Cheng L, Neumann RM, Blute ML, Zincke H, Bostwick DG.

J Natl Cancer Inst. 1998 Jul 15;90(14):1105-7. No abstract available.

PMID:
9672263
26.

Implications of using the entropy spring model for an ideal polymer chain.

Neumann RM.

Phys Rev A Gen Phys. 1986 Oct;34(4):3486-3488. No abstract available.

PMID:
9897675
27.

Nonequivalence of the stress and strain ensembles in describing polymer-chain elasticity.

Neumann RM.

Phys Rev A Gen Phys. 1985 May;31(5):3516-3517. No abstract available.

PMID:
9895923
28.

SUBSTITUTION IN THE HYDANTOIN RING. I. N-3-AMINOMETHYL DERIVATIVES.

WINSTEAD MB, BARR DE, HAMEL CR, RENN DJ, PARKER HI, NEUMANN RM.

J Med Chem. 1965 Jan;8:117-20. No abstract available.

PMID:
14287242

Supplemental Content

Loading ...
Support Center